Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LaFleur Advancing Restart of Beacon Gold Mill and Bulk Sample for Swanson Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Biotechnology
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(194)
•••
Daudau11
X
Comment by
Daudau11
on Aug 30, 2024 10:57am
RE:RE:Double
Well they did state that Revenues will double and profits will do the same as well post acquisition so its not pure speculation. Unless you believe those statements are made up lies and need to
...more
(76)
•••
colourama
X
Comment by
colourama
on Aug 29, 2024 6:46pm
RE:Double
An amazing run for sure, but it just seems a bit too much euphoria for me - no real concrete numbers of the acquisition yet to assess and yet has blown up on speculation. Sad to say I bought 10,000
...more
(6288)
•••
retiredcf
X
Post by
retiredcf
on Aug 29, 2024 10:30am
Double
Been at this a long time but aside from some of the unrealistic early days of the MJ stocks, at just over a month, this is one of the fastest doubles I have seen. Kicking myself because I was a bit
...more
(194)
•••
Daudau11
X
Post by
Daudau11
on Aug 28, 2024 1:44pm
Small Cap Discovery Update
Cipher Pharmaceuticals (TSX.V: CPH) Update with CEO Craig Mull - YouTube
(6288)
•••
retiredcf
X
Post by
retiredcf
on Aug 27, 2024 3:54pm
Keystone Financial
Ryan Irvine begins at the 5 min mark and right off the bat, he's talking about CPH. GLTA https://mikesmoneytalks.ca/august-24-episode/
(6288)
•••
retiredcf
X
Post by
retiredcf
on Aug 26, 2024 12:28pm
Ink Research
August 26, 2024 - As investors cheered the prospect of Federal Reserve rate cuts in the fall, the INK Canadian Insider Index rallied 1.49% last week. That left it up 15.08% year-to-date, closing
...more
(194)
•••
Daudau11
X
Comment by
Daudau11
on Aug 26, 2024 8:19am
RE:RE:Planet MicroCap Latest Interview
You welcome, glad you enjoyed it!!
(42)
•••
Teccing
X
Comment by
Teccing
on Aug 24, 2024 9:43am
RE:Planet MicroCap Latest Interview
Thanks for sharing link, very informative!
(194)
•••
Daudau11
X
Post by
Daudau11
on Aug 21, 2024 8:20am
Planet MicroCap Latest Interview
Cipher (TSX: CPH) (OTCQX: CPHRF): Specialty Pharmaceuticals Focused on Dermatology Products (youtube.com)
(6288)
•••
retiredcf
X
Post by
retiredcf
on Aug 18, 2024 12:56pm
Keystone Financial
If you attended KeyStone’s Fall 2023 Live Webinars and became a client to our Small-Cap Research, below we provide Quick Updates on the first two Canadian Small-Cap Recommendations new clients
...more
(1784)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Aug 18, 2024 6:17am
Donville Kent July newsletter update
Cipher Pharmaceuticals (CPH) Cipher might be a familiar name as we invested in the company from 2013-2015. At the time they had a very successful acne product and were growing extremely quick and
...more
(6288)
•••
retiredcf
X
Post by
retiredcf
on Aug 13, 2024 9:12am
Stifel
Stifel analyst Justin Keywood expects continued market volatility in the North American pharmaceuticals sector, pointing to “macro uncertainty as the U.S. election approaches.” “We see a general
...more
(6288)
•••
retiredcf
X
Comment by
retiredcf
on Aug 12, 2024 1:22pm
RE:Keystone Financial discusses CPH
Here are the related notes. GLTA In a down market over the past week, Brett reviews a shining star from KeyStone’s Canadian Small-Cap Research, Cipher Pharmaceuticals (CPH:TSX) – the stock was
...more
(1784)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Aug 11, 2024 12:41am
Divergent Capital Investment research - Substack
https://divergentcapital7651.substack.com/p/initial-thoughts-on-ciphers-acquisition/comment/63996440 Initial Thoughts on Cipher's Acquisition of ParaPRO's, "Natroba" Cipher
...more
(57)
•••
mjh9413
X
Comment by
mjh9413
on Aug 09, 2024 12:10am
RE:Acquisition Reaction
All sounds good at first blush but I see the comment in NR that "Spinosad, a topical treatment for both head lice and scabies. There are currently no generic alternatives for these products"
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Have you held units of a TD mutual fund through a discount broker? Learn more.
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining